Birru, S.K.; Doxiadis, I.; Howe, R.; Kelemu, T.; Chala, S.H.; Sherif, A.; Tadesse, F.; Tsegaye, A.; Gebremedhin, A.; Lehmann, C.
Prognostic Role of Human Leukocyte Antigen Alleles and Cytokine Single-Nucleotide Polymorphisms in Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitor Drugs. Genes 2024, 15, 732.
https://doi.org/10.3390/genes15060732
AMA Style
Birru SK, Doxiadis I, Howe R, Kelemu T, Chala SH, Sherif A, Tadesse F, Tsegaye A, Gebremedhin A, Lehmann C.
Prognostic Role of Human Leukocyte Antigen Alleles and Cytokine Single-Nucleotide Polymorphisms in Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitor Drugs. Genes. 2024; 15(6):732.
https://doi.org/10.3390/genes15060732
Chicago/Turabian Style
Birru, Samuel Kinde, Ilias Doxiadis, Rawleigh Howe, Tsehayneh Kelemu, Saifu Hailu Chala, Abdulaziz Sherif, Fisihatsion Tadesse, Aster Tsegaye, Amha Gebremedhin, and Claudia Lehmann.
2024. "Prognostic Role of Human Leukocyte Antigen Alleles and Cytokine Single-Nucleotide Polymorphisms in Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitor Drugs" Genes 15, no. 6: 732.
https://doi.org/10.3390/genes15060732
APA Style
Birru, S. K., Doxiadis, I., Howe, R., Kelemu, T., Chala, S. H., Sherif, A., Tadesse, F., Tsegaye, A., Gebremedhin, A., & Lehmann, C.
(2024). Prognostic Role of Human Leukocyte Antigen Alleles and Cytokine Single-Nucleotide Polymorphisms in Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitor Drugs. Genes, 15(6), 732.
https://doi.org/10.3390/genes15060732
